Combination of branched-chain amino acid and angiotensin-converting enzyme inhibitor improves liver fibrosis progression in patients with cirrhosis.

Molecular medicine reports2012Yoshiji H, Noguchi R, Ikenaka Y, et al.

Study designRandomized controlled trial

SubjectHuman

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

Amino Acids, Branched-ChainAngiotensin-Converting Enzyme InhibitorsCollagen Type IVDrug Therapy, CombinationFemaleHumansHyaluronic AcidInsulin ResistanceLiver CirrhosisMaleMiddle AgedPerindoprilTransforming Growth Factor betaTreatment Outcome

DOI 10.3892/mmr.2011.676

PMID 22089860

View source →